Empty Capsules Market by Type (Gelatin, Non-gelatin), Functionality (Immediate-Release, Sustained-Release, Delayed Release), Therapeutic Application, End User (Pharmaceutical, Nutraceutical, Cosmetic, Reference Laboratories) & Region - Global Forecasts to 2028
The global empty capsules market size is projected to reach USD 4.9 billion by 2028 from USD 3.2 billion in 2023, at a CAGR of 9.3% during the forecast period. Factors such as increasing use of nutraceuticals and benefits associated with empty capsules, are driving the market growth at a faster pace.
“The non-gelatin capsules segment is likely to grow at highest CAGR during the forecast period of 2023-2028.”
On the basis of type, the empty capsules market is segmented into gelatin capsules, and non-gelatin capsules. The non-gelatin capsules segment is projected to grow at the highest CAGR during the forecast period. The growth is attributed to increasing demand of vegetarian products. This is likely to have a positive impact on segmental growth.
“The immediate-release capsules segment is expected to hold a dominant share in 2023.”
Based on the functionality, the market is segmented into immediate-release capsules, sustained-release capsules, and delayed-release capsules. The immediate release capsules segment is expected to grow at a faster pace during the forecast period due to its advantages such as higher bioavailability, easy digestion, and low cost.
“In 2022, the antibiotic & antibacterial drugs segment held a dominant share.”
Based on therapeutic application, the empty capsules market is segmented into antibiotic & antibacterial drugs, dietary supplements, antacid & antiflatulent preparations, antianemic preparations, anti-inflammatory drugs, cardiovascular therapy drugs, cough & cold drugs, and other therapeutic applications. The antibiotic & antibacterial drugs segment held a dominant share of the empty capsules market. Development of new antibiotics in capsule dosage form to project the market growth.
“The nutraceutical industry segment is likely to grow at highest CAGR during the forecast period of 2023-2028.”
Based on end user, the empty capsules market is segmented into pharmaceutical industry, nutraceutical industry, cosmetic industry, and reference laboratories. The nutraceutical industry segment to grow at the highest CAGR during the forecast period. The growing use of dietary supplements is one of the major factors anticipated to project market growth.
“Asia Pacific region is likely to grow at faster pace.”
The empty capsules market is divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2022, North America accounted for the dominant share of empty capsules market. The dominance of the region is attributable to various factors such as the presence of dominant and key market players in the region coupled with increasing use of dietary supplements. Asia Pacific region is likely to grow at a faster pace owing to various factors such as the low cost of manufacturing, rising scientific research in the region, and the emergence of new market players in the empty capsules market.
The primary interviews conducted for this report can be categorized as follows:
This report provides a detailed picture of the empty capsules market. It aims at estimating the size and future growth potential of the market across different segments, such as type, functionality, therapeutic application, end user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall empty capsules market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.
“The non-gelatin capsules segment is likely to grow at highest CAGR during the forecast period of 2023-2028.”
On the basis of type, the empty capsules market is segmented into gelatin capsules, and non-gelatin capsules. The non-gelatin capsules segment is projected to grow at the highest CAGR during the forecast period. The growth is attributed to increasing demand of vegetarian products. This is likely to have a positive impact on segmental growth.
“The immediate-release capsules segment is expected to hold a dominant share in 2023.”
Based on the functionality, the market is segmented into immediate-release capsules, sustained-release capsules, and delayed-release capsules. The immediate release capsules segment is expected to grow at a faster pace during the forecast period due to its advantages such as higher bioavailability, easy digestion, and low cost.
“In 2022, the antibiotic & antibacterial drugs segment held a dominant share.”
Based on therapeutic application, the empty capsules market is segmented into antibiotic & antibacterial drugs, dietary supplements, antacid & antiflatulent preparations, antianemic preparations, anti-inflammatory drugs, cardiovascular therapy drugs, cough & cold drugs, and other therapeutic applications. The antibiotic & antibacterial drugs segment held a dominant share of the empty capsules market. Development of new antibiotics in capsule dosage form to project the market growth.
“The nutraceutical industry segment is likely to grow at highest CAGR during the forecast period of 2023-2028.”
Based on end user, the empty capsules market is segmented into pharmaceutical industry, nutraceutical industry, cosmetic industry, and reference laboratories. The nutraceutical industry segment to grow at the highest CAGR during the forecast period. The growing use of dietary supplements is one of the major factors anticipated to project market growth.
“Asia Pacific region is likely to grow at faster pace.”
The empty capsules market is divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2022, North America accounted for the dominant share of empty capsules market. The dominance of the region is attributable to various factors such as the presence of dominant and key market players in the region coupled with increasing use of dietary supplements. Asia Pacific region is likely to grow at a faster pace owing to various factors such as the low cost of manufacturing, rising scientific research in the region, and the emergence of new market players in the empty capsules market.
The primary interviews conducted for this report can be categorized as follows:
- By Respondent: Supply Side- 90%, and Demand Side - 10%
- By Designation (Supply Side): Managers - 35%, CXOs & Directors - 20%, Executives- 45%
- By Region: North America -20%, Europe -25%, Asia-Pacific -40%, Latin America -10%, and Middle East and Africa -5%
- Capsugel (US)
- ACG Worldwide (India)
- Mitsubishi Chemical Holding Corporation (US)
- CapsCanada Corporation (Canada)
- Natural Capsules (India)
- Suheung Co., Ltd. (South Korea)
- Nectar Lifesciences Ltd. (India)
- Qingdao Yiqing Medicinal Capsule (China)
- Shanxi Guangsheng Medicinal Capsule (China)
- Health Caps India (India)
- Medi-Caps (India)
- Snail Pharma Industry (China)
- Roxlor (US)
- Sunil Healthcare (India)
- BioCaps Enterprise (US)
- Bright Pharma Caps (US)
- Comed Chemicals (India)
- Saviour Caps (India)
- Fortcaps Healthcare (India)
- Shaoxing Zhongya Capsule (China)
- Erawat Pharma (India)
- Farmacapsulas (Colombia)
- Zhejiang Yuexi Capsule (Taiwan)
- LFA Machines Oxfords (US)
- Shaoxing Kangke (China)
- Shree Pharma Caps (India)
This report provides a detailed picture of the empty capsules market. It aims at estimating the size and future growth potential of the market across different segments, such as type, functionality, therapeutic application, end user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall empty capsules market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKET SCOPE
FIGURE 1 EMPTY CAPSULES MARKET SEGMENTATION
1.3.1 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
1.7.1 RECESSION IMPACT
2 RESEARCH METHODOLOGY
2.1 RESEARCH APPROACH
FIGURE 2 RESEARCH DESIGN
2.1.1 SECONDARY RESEARCH
2.1.2 PRIMARY RESEARCH
FIGURE 3 EMPTY CAPSULES MARKET: PRIMARY RESPONDENTS
2.2 MARKET ESTIMATION METHODOLOGY
FIGURE 4 EMPTY CAPSULES MARKET SIZE ESTIMATION, BY VALUE (2022)
FIGURE 5 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2022
FIGURE 6 MARKET VOLUME ESTIMATION, 2022
2.2.1 INSIGHTS FROM PRIMARY EXPERTS
FIGURE 7 INSIGHTS ON EMPTY CAPSULES MARKET FROM PRIMARY EXPERTS
2.3 MARKET GROWTH RATE PROJECTIONS
FIGURE 8 EMPTY CAPSULES MARKET (DEMAND SIDE): GROWTH ANALYSIS OF DEMAND-SIDE FACTORS
2.4 DATA TRIANGULATION
FIGURE 9 DATA TRIANGULATION METHODOLOGY
2.5 RESEARCH ASSUMPTIONS
2.6 RISK ANALYSIS
3 EXECUTIVE SUMMARY
FIGURE 10 EMPTY CAPSULES MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION)
FIGURE 11 EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2023 VS. 2028 (USD MILLION)
FIGURE 12 EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2023 VS. 2028 (USD MILLION)
FIGURE 13 EMPTY CAPSULES MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
FIGURE 14 GEOGRAPHICAL SNAPSHOT OF EMPTY CAPSULES MARKET
4 PREMIUM INSIGHTS
4.1 EMPTY CAPSULES MARKET OVERVIEW
FIGURE 15 INCREASING DEMAND FOR NUTRACEUTICALS TO DRIVE GROWTH
4.2 NORTH AMERICA: EMPTY CAPSULES MARKET, BY TYPE AND COUNTRY (2022)
FIGURE 16 GELATIN CAPSULES ACCOUNTED FOR LARGEST MARKET SHARE IN 2022
4.3 EMPTY CAPSULES MARKET SHARE, BY APPLICATION, 2023 VS. 2028
FIGURE 17 ANTIBIOTIC AND ANTIBACTERIAL DRUGS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
4.4 EMPTY CAPSULES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 18 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 19 EMPTY CAPSULES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
TABLE 1 EMPTY CAPSULES MARKET: IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Increasing demand for nutraceuticals
5.2.1.2 Growth in pharmaceutical market and increasing number of clinical trials and R&D activities
5.2.1.3 Advancements in capsule delivery technologies
5.2.1.4 Benefits of capsules over other dosage forms
5.2.2 RESTRAINTS
5.2.2.1 Cultural practices and dietary restrictions
5.2.3 OPPORTUNITIES
5.2.3.1 Expansion of capsule production in emerging countries
5.2.3.2 Development of halal gelatin and vegetarian capsules
5.2.4 CHALLENGES
5.2.4.1 Rising prices and lower availability of raw materials in gelatin industry
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 20 REVENUE SHIFT AND NEW REVENUE POCKETS
5.4 PRICING ANALYSIS
TABLE 2 AVERAGE PRICE OF EMPTY CAPSULES, BY REGION (2022)
5.5 TECHNOLOGY ANALYSIS
5.5.1 ENTERIC CAPSULE TECHNOLOGIES
5.5.2 PROTEIN DELIVERY CAPSULE TECHNOLOGIES
5.6 VALUE CHAIN ANALYSIS
FIGURE 21 EMPTY CAPSULES MARKET: VALUE CHAIN ANALYSIS
5.7 ECOSYSTEM ANALYSIS
FIGURE 22 ECOSYSTEM ANALYSIS: EMPTY CAPSULES MARKET
TABLE 3 ROLE IN ECOSYSTEM
5.8 PORTER’S FIVE FORCES ANALYSIS
TABLE 4 EMPTY CAPSULES MARKET: PORTER’S FIVE FORCES ANALYSIS
5.8.1 THREAT OF NEW ENTRANTS
5.8.2 THREAT OF SUBSTITUTES
5.8.3 BARGAINING POWER OF SUPPLIERS
5.8.4 BARGAINING POWER OF BUYERS
5.8.5 INTENSITY OF COMPETITIVE RIVALRY
5.9 KEY STAKEHOLDERS AND BUYING CRITERIA
FIGURE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF EMPTY CAPSULES
FIGURE 24 KEY BUYING CRITERIA FOR EMPTY CAPSULES
5.10 PATENT ANALYSIS
FIGURE 25 PATENT APPLICATIONS RELATED TO EMPTY CAPSULES, JANUARY 2012–MARCH 2023
TABLE 5 LIST OF FEW PATENTS IN EMPTY CAPSULES MARKET
5.11 TRADE ANALYSIS
TABLE 6 EXPORT DATA FOR HS CODE 960200 (TOP 10 COUNTRIES)
TABLE 7 IMPORT DATA FOR HS CODE 960200 (TOP 10 COUNTRIES)
5.12 REGULATORY ANALYSIS
5.13 PHARMACEUTICAL GELATIN MARKET
5.14 INDUSTRY TRENDS
5.14.1 RISING DEMAND FOR EMPTY CAPSULES IN NUTRACEUTICAL AND COSMETICS INDUSTRIES
5.14.2 GROWING DEMAND AND ADOPTION OF VEGETARIAN/NON-GELATIN CAPSULES
6 EMPTY CAPSULES MARKET, BY TYPE
6.1 INTRODUCTION
TABLE 8 EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 9 EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (BILLION UNITS)
6.2 GELATIN CAPSULES
TABLE 10 GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 11 GELATIN CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 12 GELATIN CAPSULES MARKET, BY REGION, 2021–2028 (BILLION UNITS)
TABLE 13 NORTH AMERICA: GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 14 EUROPE: GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 15 ASIA PACIFIC: GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.1 PORCINE GELATIN
6.2.1.1 Porcine gelatin segment to dominate market
TABLE 16 PORCINE GELATIN CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 17 NORTH AMERICA: PORCINE GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 18 EUROPE: PORCINE GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 19 ASIA PACIFIC: PORCINE GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.2 BOVINE-DERIVED GELATIN
6.2.2.1 Bovine-derived gelatin widely accepted in halal pharmaceuticals market
TABLE 20 BOVINE-DERIVED GELATIN CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 21 NORTH AMERICA: BOVINE-DERIVED GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 22 EUROPE: BOVINE-DERIVED GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 23 ASIA PACIFIC: BOVINE-DERIVED GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.3 BONE MEAL
6.2.3.1 Bone meal gelatin gained importance in recent years
TABLE 24 BONE MEAL GELATIN CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 25 NORTH AMERICA: BONE MEAL GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 26 EUROPE: BONE MEAL GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 27 ASIA PACIFIC: BONE MEAL GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.4 OTHER GELATIN SOURCES
TABLE 28 OTHER GELATIN SOURCE CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 29 NORTH AMERICA: OTHER GELATIN SOURCE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 30 EUROPE: OTHER GELATIN SOURCE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 31 ASIA PACIFIC: OTHER GELATIN SOURCE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.3 NON-GELATIN CAPSULES
TABLE 32 NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 33 NON-GELATIN CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 34 NON-GELATIN CAPSULES MARKET, BY REGION, 2021–2028 (BILLION UNITS)
TABLE 35 NORTH AMERICA: NON-GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 36 EUROPE: NON-GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 37 ASIA PACIFIC: NON-GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.3.1 HYDROXYPROPYL METHYLCELLULOSE
6.3.1.1 HPMC dominates non-gelatin capsules market
TABLE 38 HYDROXYPROPYL METHYLCELLULOSE CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 39 NORTH AMERICA: HYDROXYPROPYL METHYLCELLULOSE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 40 EUROPE: HYDROXYPROPYL METHYLCELLULOSE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 41 ASIA PACIFIC: HYDROXYPROPYL METHYLCELLULOSE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.3.2 PULLULAN AND STARCH
6.3.2.1 High manufacturing costs offset advantageous aspects of pullulan and starch
TABLE 42 PULLULAN AND STARCH CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 43 NORTH AMERICA: PULLULAN AND STARCH CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 44 EUROPE: PULLULAN AND STARCH CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 45 ASIA PACIFIC: PULLULAN AND STARCH CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
7 EMPTY CAPSULES MARKET, BY FUNCTIONALITY
7.1 INTRODUCTION
TABLE 46 EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
7.2 IMMEDIATE-RELEASE CAPSULES
7.2.1 INCREASING APPLICATIONS OF IMMEDIATE-RELEASE CAPSULES TO PROPEL MARKET
TABLE 47 IMMEDIATE-RELEASE CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 48 NORTH AMERICA: IMMEDIATE-RELEASE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 49 EUROPE: IMMEDIATE-RELEASE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 50 ASIA PACIFIC: IMMEDIATE-RELEASE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
7.3 SUSTAINED-RELEASE CAPSULES
7.3.1 RISING USE OF SUSTAINED-RELEASE FORMULATIONS IN TREATING CHRONIC DISEASES TO DRIVE MARKET
TABLE 51 SUSTAINED-RELEASE CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 52 NORTH AMERICA: SUSTAINED-RELEASE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 53 EUROPE: SUSTAINED-RELEASE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 54 ASIA PACIFIC: SUSTAINED-RELEASE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
7.4 DELAYED-RELEASE CAPSULES
7.4.1 GROWING PREFERENCE FOR TARGETED DRUG DELIVERY TO FUEL MARKET GROWTH
TABLE 55 DELAYED-RELEASE CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 56 NORTH AMERICA: DELAYED-RELEASE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 57 EUROPE: DELAYED-RELEASE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 58 ASIA PACIFIC: DELAYED-RELEASE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
8 EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION
8.1 INTRODUCTION
TABLE 59 EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)
8.2 ANTIBIOTIC AND ANTIBACTERIAL DRUGS
8.2.1 EMERGENCE OF NOVEL ANTIBIOTICS IN CAPSULE FORM AND INCREASING INCIDENCE OF INFECTIOUS DISEASES TO DRIVE MARKET
TABLE 60 EMPTY CAPSULES MARKET FOR ANTIBIOTIC AND ANTIBACTERIAL DRUGS, BY REGION, 2021–2028 (USD MILLION)
TABLE 61 NORTH AMERICA: EMPTY CAPSULES MARKET FOR ANTIBIOTIC AND ANTIBACTERIAL DRUGS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 62 EUROPE: EMPTY CAPSULES MARKET FOR ANTIBIOTIC AND ANTIBACTERIAL DRUGS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 63 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR ANTIBIOTIC AND ANTIBACTERIAL DRUGS, BY COUNTRY, 2021–2028 (USD MILLION)
8.3 DIETARY SUPPLEMENTS
8.3.1 RISING DEMAND FOR DIETARY SUPPLEMENTS TO SUPPORT GROWTH
TABLE 64 EMPTY CAPSULES MARKET FOR DIETARY SUPPLEMENTS, BY REGION, 2021–2028 (USD MILLION)
TABLE 65 NORTH AMERICA: EMPTY CAPSULES MARKET FOR DIETARY SUPPLEMENTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 66 EUROPE: EMPTY CAPSULES MARKET FOR DIETARY SUPPLEMENTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 67 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR DIETARY SUPPLEMENTS, BY COUNTRY, 2021–2028 (USD MILLION)
8.4 ANTACID AND ANTIFLATULENT PREPARATIONS
8.4.1 INCREASING DEMAND FOR GASTROINTESTINAL FORMULATIONS TO DRIVE MARKET
TABLE 68 EMPTY CAPSULES MARKET FOR ANTACID AND ANTIFLATULENT PREPARATIONS, BY REGION, 2021–2028 (USD MILLION)
TABLE 69 NORTH AMERICA: EMPTY CAPSULES MARKET FOR ANTACID AND ANTIFLATULENT PREPARATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 70 EUROPE: EMPTY CAPSULES MARKET FOR ANTACID AND ANTIFLATULENT PREPARATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 71 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR ANTACID AND ANTIFLATULENT PREPARATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
8.5 ANTIANEMIC PREPARATIONS
8.5.1 RISING INCIDENCE OF ANEMIA WORLDWIDE TO DRIVE GROWTH
TABLE 72 EMPTY CAPSULES MARKET FOR ANTIANEMIC PREPARATIONS, BY REGION, 2021–2028 (USD MILLION)
TABLE 73 NORTH AMERICA: EMPTY CAPSULES MARKET FOR ANTIANEMIC PREPARATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 74 EUROPE: EMPTY CAPSULES MARKET FOR ANTIANEMIC PREPARATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 75 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR ANTIANEMIC PREPARATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
8.6 ANTI-INFLAMMATORY DRUGS
8.6.1 RISING EMPHASIS ON GENERICS TO FAVOR MARKET GROWTH
TABLE 76 EMPTY CAPSULES MARKET FOR ANTI-INFLAMMATORY DRUGS, BY REGION, 2021–2028 (USD MILLION)
TABLE 77 NORTH AMERICA: EMPTY CAPSULES MARKET FOR ANTI-INFLAMMATORY DRUGS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 78 EUROPE: EMPTY CAPSULES MARKET FOR ANTI-INFLAMMATORY DRUGS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 79 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR ANTI-INFLAMMATORY DRUGS, BY COUNTRY, 2021–2028 (USD MILLION)
8.7 CARDIOVASCULAR THERAPY DRUGS
8.7.1 RISING PREVALENCE OF CARDIOVASCULAR DISEASES TO CONTRIBUTE TO MARKET GROWTH
TABLE 80 EMPTY CAPSULES MARKET FOR CARDIOVASCULAR THERAPY DRUGS, BY REGION, 2021–2028 (USD MILLION)
TABLE 81 NORTH AMERICA: EMPTY CAPSULES MARKET FOR CARDIOVASCULAR THERAPY DRUGS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 82 EUROPE: EMPTY CAPSULES MARKET FOR CARDIOVASCULAR THERAPY DRUGS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 83 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR CARDIOVASCULAR THERAPY DRUGS, BY COUNTRY, 2021–2028 (USD MILLION)
8.8 COUGH AND COLD DRUGS
8.8.1 GROWING ADOPTION OF OTC FORMULATIONS AND SELF-MEDICATION PRACTICES TO DRIVE GROWTH
TABLE 84 EMPTY CAPSULES MARKET FOR COUGH AND COLD DRUGS, BY REGION, 2021–2028 (USD MILLION)
TABLE 85 NORTH AMERICA: EMPTY CAPSULES MARKET FOR COUGH AND COLD DRUGS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 86 EUROPE: EMPTY CAPSULES MARKET FOR COUGH AND COLD DRUGS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 87 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR COUGH AND COLD DRUGS, BY COUNTRY, 2021–2028 (USD MILLION)
8.9 OTHER THERAPEUTIC APPLICATIONS
TABLE 88 EMPTY CAPSULES MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
TABLE 89 NORTH AMERICA: EMPTY CAPSULES MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 90 EUROPE: EMPTY CAPSULES MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 91 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
9 EMPTY CAPSULES MARKET, BY END USER
9.1 INTRODUCTION
TABLE 92 EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION)
9.2 PHARMACEUTICAL INDUSTRY
9.2.1 INCREASING EMPHASIS ON DRUG DEVELOPMENT TO DRIVE GROWTH
TABLE 93 EMPTY CAPSULES MARKET FOR PHARMACEUTICAL INDUSTRY, BY REGION, 2021–2028 (USD MILLION)
TABLE 94 NORTH AMERICA: EMPTY CAPSULES MARKET FOR PHARMACEUTICAL INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 95 EUROPE: EMPTY CAPSULES MARKET FOR PHARMACEUTICAL INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 96 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR PHARMACEUTICAL INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION)
9.3 NUTRACEUTICAL INDUSTRY
9.3.1 INCREASING DEMAND FOR DIETARY SUPPLEMENTS IN DEVELOPED AND DEVELOPING COUNTRIES TO SUPPORT GROWTH
TABLE 97 EMPTY CAPSULES MARKET FOR NUTRACEUTICAL INDUSTRY, BY REGION, 2021–2028 (USD MILLION)
TABLE 98 NORTH AMERICA: EMPTY CAPSULES MARKET FOR NUTRACEUTICAL INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 99 EUROPE: EMPTY CAPSULES MARKET FOR NUTRACEUTICAL INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 100 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR NUTRACEUTICAL INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION)
9.4 COSMETICS INDUSTRY
9.4.1 GELATIN-BASED CAPSULES ARE IDEAL FOR DELIVERING COSMETIC PRODUCTS
TABLE 101 EMPTY CAPSULES MARKET FOR COSMETICS INDUSTRY, BY REGION, 2021–2028 (USD MILLION)
TABLE 102 NORTH AMERICA: EMPTY CAPSULES MARKET FOR COSMETICS INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 103 EUROPE: EMPTY CAPSULES MARKET FOR COSMETICS INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 104 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR COSMETICS INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION)
9.5 RESEARCH LABORATORIES
9.5.1 RISING CLINICAL TRIAL ACTIVITY TO DRIVE MARKET GROWTH
TABLE 105 EMPTY CAPSULES MARKET FOR RESEARCH LABORATORIES, BY REGION, 2021–2028 (USD MILLION)
TABLE 106 NORTH AMERICA: EMPTY CAPSULES MARKET FOR RESEARCH LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 107 EUROPE: EMPTY CAPSULES MARKET FOR RESEARCH LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 108 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR RESEARCH LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION)
10 EMPTY CAPSULES MARKET, BY REGION
10.1 INTRODUCTION
TABLE 109 EMPTY CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 110 EMPTY CAPSULES MARKET, BY REGION, 2021–2028 (BILLION UNITS)
10.2 NORTH AMERICA
FIGURE 26 NORTH AMERICA: EMPTY CAPSULES MARKET SNAPSHOT
TABLE 111 NORTH AMERICA: EMPTY CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 112 NORTH AMERICA: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 113 NORTH AMERICA: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 114 NORTH AMERICA: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 115 NORTH AMERICA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
TABLE 116 NORTH AMERICA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)
TABLE 117 NORTH AMERICA: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION)
10.2.1 US
10.2.1.1 US to dominate North American market during forecast period
TABLE 118 US: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 119 US: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 120 US: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 121 US: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
TABLE 122 US: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)
TABLE 123 US: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION)
10.2.2 CANADA
10.2.2.1 Rising government focus on utilization of generics as means for controlling healthcare expenditure to drive growth
TABLE 124 CANADA: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 125 CANADA: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 126 CANADA: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 127 CANADA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
TABLE 128 CANADA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)
TABLE 129 CANADA: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION)
10.2.3 NORTH AMERICA: RECESSION IMPACT
10.3 EUROPE
TABLE 130 EUROPE: EMPTY CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 131 EUROPE: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 132 EUROPE: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 133 EUROPE: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 134 EUROPE: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
TABLE 135 EUROPE: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)
TABLE 136 EUROPE: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.1 GERMANY
10.3.1.1 Presence of large number of pharmaceutical and nutraceutical manufacturers propelling demand for empty capsules
TABLE 137 GERMANY: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 138 GERMANY: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 139 GERMANY: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 140 GERMANY: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
TABLE 141 GERMANY: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)
TABLE 142 GERMANY: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.2 UK
10.3.2.1 Rising adoption of generics to drive market growth
TABLE 143 UK: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 144 UK: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 145 UK: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 146 UK: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
TABLE 147 UK: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)
TABLE 148 UK: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.3 FRANCE
10.3.3.1 High demand for pharmaceutical products to drive market growth
TABLE 149 FRANCE: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 150 FRANCE: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 151 FRANCE: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 152 FRANCE: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
TABLE 153 FRANCE: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)
TABLE 154 FRANCE: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.4 ITALY
10.3.4.1 Growing presence of small and medium-sized CMOs likely to drive market
TABLE 155 ITALY: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 156 ITALY: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 157 ITALY: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 158 ITALY: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
TABLE 159 ITALY: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)
TABLE 160 ITALY: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.5 SPAIN
10.3.5.1 Consolidation of biotechnology sector and availability of government support to drive growth
TABLE 161 SPAIN: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 162 SPAIN: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 163 SPAIN: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 164 SPAIN: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
TABLE 165 SPAIN: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)
TABLE 166 SPAIN: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.6 REST OF EUROPE
TABLE 167 REST OF EUROPE: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 168 REST OF EUROPE: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 169 REST OF EUROPE: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 170 REST OF EUROPE: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
TABLE 171 REST OF EUROPE: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)
TABLE 172 REST OF EUROPE: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.7 EUROPE: RECESSION IMPACT
10.4 ASIA PACIFIC
FIGURE 27 ASIA PACIFIC: EMPTY CAPSULES MARKET SNAPSHOT
TABLE 173 ASIA PACIFIC: EMPTY CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 174 ASIA PACIFIC: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 175 ASIA PACIFIC: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 176 ASIA PACIFIC: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 177 ASIA PACIFIC: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
TABLE 178 ASIA PACIFIC: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)
TABLE 179 ASIA PACIFIC: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION)
10.4.1 CHINA
10.4.1.1 Low manufacturing costs on account of availability of raw materials to accelerate growth
TABLE 180 CHINA: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 181 CHINA: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 182 CHINA: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 183 CHINA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
TABLE 184 CHINA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)
TABLE 185 CHINA: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION)
10.4.2 JAPAN
10.4.2.1 Japan to be largest market for empty capsules in Asia Pacific
TABLE 186 JAPAN: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 187 JAPAN: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 188 JAPAN: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 189 JAPAN: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
TABLE 190 JAPAN: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)
TABLE 191 JAPAN: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION)
10.4.3 INDIA
10.4.3.1 Increased exports of empty capsules to drive market growth
TABLE 192 INDIA: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 193 INDIA: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 194 INDIA: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 195 INDIA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
TABLE 196 INDIA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)
TABLE 197 INDIA: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION)
10.4.4 REST OF ASIA PACIFIC
TABLE 198 REST OF ASIA PACIFIC: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 199 REST OF ASIA PACIFIC: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 200 REST OF ASIA PACIFIC: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 201 REST OF ASIA PACIFIC: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
TABLE 202 REST OF ASIA PACIFIC: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)
TABLE 203 REST OF ASIA PACIFIC: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION)
10.4.5 ASIA PACIFIC: RECESSION IMPACT
10.5 LATIN AMERICA
10.5.1 STRATEGIC EXPANSIONS BY LEADING MARKET PLAYERS TO DRIVE GROWTH
TABLE 204 LATIN AMERICA: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 205 LATIN AMERICA: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 206 LATIN AMERICA: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 207 LATIN AMERICA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
TABLE 208 LATIN AMERICA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)
TABLE 209 LATIN AMERICA: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION)
10.5.2 LATIN AMERICA: RECESSION IMPACT
10.6 MIDDLE EAST & AFRICA
10.6.1 GROWING PHARMACEUTICAL INDUSTRY TO DRIVE MARKET
TABLE 210 MIDDLE EAST & AFRICA: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 211 MIDDLE EAST & AFRICA: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 212 MIDDLE EAST & AFRICA: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 213 MIDDLE EAST & AFRICA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
TABLE 214 MIDDLE EAST & AFRICA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)
TABLE 215 MIDDLE EAST & AFRICA: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION)
10.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT
11 COMPETITIVE LANDSCAPE
11.1 INTRODUCTION
11.2 RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS
FIGURE 28 EMPTY CAPSULES MARKET: STRATEGIES ADOPTED
11.3 MARKET SHARE ANALYSIS
FIGURE 29 EMPTY CAPSULES MARKET: MARKET SHARE ANALYSIS, BY KEY PLAYER (2022)
TABLE 216 EMPTY CAPSULES MARKET: DEGREE OF COMPETITION
11.4 REVENUE ANALYSIS
FIGURE 30 REVENUE ANALYSIS FOR KEY COMPANIES (2020–2022)
11.5 COMPANY EVALUATION MATRIX
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 PARTICIPANTS
FIGURE 31 EMPTY CAPSULES MARKET: COMPANY EVALUATION MATRIX, 2022
11.6 COMPANY EVALUATION MATRIX FOR START-UPS/SMES
11.6.1 PROGRESSIVE COMPANIES
11.6.2 STARTING BLOCKS
11.6.3 RESPONSIVE COMPANIES
11.6.4 DYNAMIC COMPANIES
FIGURE 32 EMPTY CAPSULES MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2022
11.7 COMPETITIVE BENCHMARKING OF TOP 25 PLAYERS
11.7.1 OVERALL COMPANY FOOTPRINT (25 COMPANIES)
TABLE 217 OVERALL FOOTPRINT ANALYSIS OF KEY PLAYERS
11.7.2 INDUSTRY FOOTPRINT OF COMPANIES (25 COMPANIES)
TABLE 218 INDUSTRY FOOTPRINT ANALYSIS OF KEY PLAYERS
11.7.3 REGIONAL FOOTPRINT OF COMPANIES (25 COMPANIES)
TABLE 219 REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS
11.7.4 OFFERING FOOTPRINT OF COMPANIES (25 COMPANIES)
TABLE 220 OFFERING FOOTPRINT ANALYSIS OF KEY PLAYERS
11.8 COMPETITIVE BENCHMARKING OF START-UPS/SMES
TABLE 221 EMPTY CAPSULES MARKET: DETAILED LIST OF KEY START-UPS/SMES
TABLE 222 EMPTY CAPSULES MARKET: COMPETITIVE BENCHMARKING OF START-UPS/SMES
11.9 COMPETITIVE SCENARIO AND TRENDS
11.9.1 PRODUCT LAUNCHES
TABLE 223 EMPTY CAPSULES MARKET: PRODUCT LAUNCHES, JANUARY 2020–MARCH 2023
11.9.2 DEALS
TABLE 224 EMPTY CAPSULES MARKET: DEALS, JANUARY 2020–MARCH 2023
11.9.3 OTHER DEVELOPMENTS
TABLE 225 EMPTY CAPSULES MARKET: OTHER DEVELOPMENTS, JANUARY 2020–MARCH 2023
12 COMPANY PROFILES
(Business Overview, Products Offered, Recent Developments, MnM View Right to win, Strategic choices made, Weaknesses and competitive threats) *
12.1 KEY PLAYERS
12.1.1 CAPSUGEL (LONZA GROUP LTD.)
TABLE 226 CAPSUGEL (LONZA GROUP): BUSINESS OVERVIEW
FIGURE 33 LONZA GROUP LTD.: COMPANY SNAPSHOT (2022)
12.1.2 ACG
TABLE 227 ACG: BUSINESS OVERVIEW
12.1.3 MITSUBISHI CHEMICAL HOLDINGS CORPORATION
TABLE 228 QUALICAPS (MITSUBISHI CHEMICAL HOLDINGS CORPORATION): BUSINESS OVERVIEW
FIGURE 34 QUALICAPS (MITSUBISHI CHEMICAL HOLDINGS CORPORATION): COMPANY SNAPSHOT (2021)
12.1.4 CAPSCANADA CORPORATION
TABLE 229 CAPSCANADA CORPORATION: BUSINESS OVERVIEW
12.1.5 NATURAL CAPSULES
TABLE 230 NATURAL CAPSULES: BUSINESS OVERVIEW
FIGURE 35 NATURAL CAPSULES: COMPANY SNAPSHOT (2021)
12.1.6 SUHEUNG
TABLE 231 SUHEUNG: BUSINESS OVERVIEW
12.1.7 NECTAR LIFESCIENCES LTD.
TABLE 232 NECTAR LIFESCIENCES LTD.: BUSINESS OVERVIEW
FIGURE 36 NECTAR LIFESCIENCES LTD.: COMPANY SNAPSHOT (2021)
12.1.8 QINGDAO YIQING MEDICINAL CAPSULE (BAOTOU DONGBAO BIOTECHNOLOGY CO., LTD.)
TABLE 233 QINGDAO YIQING MEDICINAL CAPSULE: BUSINESS OVERVIEW
12.1.9 SHANXI GUANGSHENG MEDICINAL CAPSULE
TABLE 234 SHANXI GUANGSHENG MEDICINAL CAPSULE: BUSINESS OVERVIEW
12.1.10 HEALTHCAPS INDIA
TABLE 235 HEALTHCAPS INDIA: BUSINESS OVERVIEW
12.1.11 MEDI-CAPS
TABLE 236 MEDI-CAPS: BUSINESS OVERVIEW
FIGURE 37 MEDI-CAPS: COMPANY SNAPSHOT (2021)
12.1.12 SNAIL PHARMA INDUSTRY
TABLE 237 SNAIL PHARMA INDUSTRY: BUSINESS OVERVIEW
12.1.13 ROXLOR
TABLE 238 ROXLOR: BUSINESS OVERVIEW
12.1.14 SUNIL HEALTHCARE
TABLE 239 SUNIL HEALTHCARE: BUSINESS OVERVIEW
FIGURE 38 SUNIL HEALTHCARE: COMPANY SNAPSHOT (2021)
12.1.15 BIOCAPS ENTERPRISE
TABLE 240 BIOCAPS ENTERPRISE: BUSINESS OVERVIEW
12.1.16 BRIGHT PHARMA CAPS
TABLE 241 BRIGHT PHARMA CAPS: BUSINESS OVERVIEW
12.2 OTHER COMPANIES
12.2.1 COMED CHEMICALS
TABLE 242 COMED CHEMICALS: BUSINESS OVERVIEW
12.2.2 SAVIOUR CAPS
TABLE 243 SAVIOUR CAPS: BUSINESS OVERVIEW
12.2.3 FORTCAPS HEALTHCARE
TABLE 244 FORTCAPS HEALTHCARE: BUSINESS OVERVIEW
12.2.4 SHAOXING ZHONGYA CAPSULE
TABLE 245 SHAOXING ZHONGYA CAPSULE: BUSINESS OVERVIEW
12.2.5 ERAWAT PHARMA LIMITED
TABLE 246 ERAWAT PHARMA LIMITED: BUSINESS OVERVIEW
12.2.6 FARMACAPSULAS
TABLE 247 FARMACAPSULAS: BUSINESS OVERVIEW
12.2.7 ZHEJIANG YUEXI CAPSULE
12.2.8 LFA MACHINES OXFORD
12.2.9 SHAOXING KANGKE CAPSULE
12.2.10 SHREE PHARMA CAPS
*Details on Business Overview, Products Offered, Recent Developments, MnM View, Right to win, Strategic choices made, Weaknesses and competitive threats might not be captured in case of unlisted companies.
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKET SCOPE
FIGURE 1 EMPTY CAPSULES MARKET SEGMENTATION
1.3.1 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
1.7.1 RECESSION IMPACT
2 RESEARCH METHODOLOGY
2.1 RESEARCH APPROACH
FIGURE 2 RESEARCH DESIGN
2.1.1 SECONDARY RESEARCH
2.1.2 PRIMARY RESEARCH
FIGURE 3 EMPTY CAPSULES MARKET: PRIMARY RESPONDENTS
2.2 MARKET ESTIMATION METHODOLOGY
FIGURE 4 EMPTY CAPSULES MARKET SIZE ESTIMATION, BY VALUE (2022)
FIGURE 5 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2022
FIGURE 6 MARKET VOLUME ESTIMATION, 2022
2.2.1 INSIGHTS FROM PRIMARY EXPERTS
FIGURE 7 INSIGHTS ON EMPTY CAPSULES MARKET FROM PRIMARY EXPERTS
2.3 MARKET GROWTH RATE PROJECTIONS
FIGURE 8 EMPTY CAPSULES MARKET (DEMAND SIDE): GROWTH ANALYSIS OF DEMAND-SIDE FACTORS
2.4 DATA TRIANGULATION
FIGURE 9 DATA TRIANGULATION METHODOLOGY
2.5 RESEARCH ASSUMPTIONS
2.6 RISK ANALYSIS
3 EXECUTIVE SUMMARY
FIGURE 10 EMPTY CAPSULES MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION)
FIGURE 11 EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2023 VS. 2028 (USD MILLION)
FIGURE 12 EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2023 VS. 2028 (USD MILLION)
FIGURE 13 EMPTY CAPSULES MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
FIGURE 14 GEOGRAPHICAL SNAPSHOT OF EMPTY CAPSULES MARKET
4 PREMIUM INSIGHTS
4.1 EMPTY CAPSULES MARKET OVERVIEW
FIGURE 15 INCREASING DEMAND FOR NUTRACEUTICALS TO DRIVE GROWTH
4.2 NORTH AMERICA: EMPTY CAPSULES MARKET, BY TYPE AND COUNTRY (2022)
FIGURE 16 GELATIN CAPSULES ACCOUNTED FOR LARGEST MARKET SHARE IN 2022
4.3 EMPTY CAPSULES MARKET SHARE, BY APPLICATION, 2023 VS. 2028
FIGURE 17 ANTIBIOTIC AND ANTIBACTERIAL DRUGS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
4.4 EMPTY CAPSULES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 18 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 19 EMPTY CAPSULES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
TABLE 1 EMPTY CAPSULES MARKET: IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Increasing demand for nutraceuticals
5.2.1.2 Growth in pharmaceutical market and increasing number of clinical trials and R&D activities
5.2.1.3 Advancements in capsule delivery technologies
5.2.1.4 Benefits of capsules over other dosage forms
5.2.2 RESTRAINTS
5.2.2.1 Cultural practices and dietary restrictions
5.2.3 OPPORTUNITIES
5.2.3.1 Expansion of capsule production in emerging countries
5.2.3.2 Development of halal gelatin and vegetarian capsules
5.2.4 CHALLENGES
5.2.4.1 Rising prices and lower availability of raw materials in gelatin industry
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 20 REVENUE SHIFT AND NEW REVENUE POCKETS
5.4 PRICING ANALYSIS
TABLE 2 AVERAGE PRICE OF EMPTY CAPSULES, BY REGION (2022)
5.5 TECHNOLOGY ANALYSIS
5.5.1 ENTERIC CAPSULE TECHNOLOGIES
5.5.2 PROTEIN DELIVERY CAPSULE TECHNOLOGIES
5.6 VALUE CHAIN ANALYSIS
FIGURE 21 EMPTY CAPSULES MARKET: VALUE CHAIN ANALYSIS
5.7 ECOSYSTEM ANALYSIS
FIGURE 22 ECOSYSTEM ANALYSIS: EMPTY CAPSULES MARKET
TABLE 3 ROLE IN ECOSYSTEM
5.8 PORTER’S FIVE FORCES ANALYSIS
TABLE 4 EMPTY CAPSULES MARKET: PORTER’S FIVE FORCES ANALYSIS
5.8.1 THREAT OF NEW ENTRANTS
5.8.2 THREAT OF SUBSTITUTES
5.8.3 BARGAINING POWER OF SUPPLIERS
5.8.4 BARGAINING POWER OF BUYERS
5.8.5 INTENSITY OF COMPETITIVE RIVALRY
5.9 KEY STAKEHOLDERS AND BUYING CRITERIA
FIGURE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF EMPTY CAPSULES
FIGURE 24 KEY BUYING CRITERIA FOR EMPTY CAPSULES
5.10 PATENT ANALYSIS
FIGURE 25 PATENT APPLICATIONS RELATED TO EMPTY CAPSULES, JANUARY 2012–MARCH 2023
TABLE 5 LIST OF FEW PATENTS IN EMPTY CAPSULES MARKET
5.11 TRADE ANALYSIS
TABLE 6 EXPORT DATA FOR HS CODE 960200 (TOP 10 COUNTRIES)
TABLE 7 IMPORT DATA FOR HS CODE 960200 (TOP 10 COUNTRIES)
5.12 REGULATORY ANALYSIS
5.13 PHARMACEUTICAL GELATIN MARKET
5.14 INDUSTRY TRENDS
5.14.1 RISING DEMAND FOR EMPTY CAPSULES IN NUTRACEUTICAL AND COSMETICS INDUSTRIES
5.14.2 GROWING DEMAND AND ADOPTION OF VEGETARIAN/NON-GELATIN CAPSULES
6 EMPTY CAPSULES MARKET, BY TYPE
6.1 INTRODUCTION
TABLE 8 EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 9 EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (BILLION UNITS)
6.2 GELATIN CAPSULES
TABLE 10 GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 11 GELATIN CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 12 GELATIN CAPSULES MARKET, BY REGION, 2021–2028 (BILLION UNITS)
TABLE 13 NORTH AMERICA: GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 14 EUROPE: GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 15 ASIA PACIFIC: GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.1 PORCINE GELATIN
6.2.1.1 Porcine gelatin segment to dominate market
TABLE 16 PORCINE GELATIN CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 17 NORTH AMERICA: PORCINE GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 18 EUROPE: PORCINE GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 19 ASIA PACIFIC: PORCINE GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.2 BOVINE-DERIVED GELATIN
6.2.2.1 Bovine-derived gelatin widely accepted in halal pharmaceuticals market
TABLE 20 BOVINE-DERIVED GELATIN CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 21 NORTH AMERICA: BOVINE-DERIVED GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 22 EUROPE: BOVINE-DERIVED GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 23 ASIA PACIFIC: BOVINE-DERIVED GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.3 BONE MEAL
6.2.3.1 Bone meal gelatin gained importance in recent years
TABLE 24 BONE MEAL GELATIN CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 25 NORTH AMERICA: BONE MEAL GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 26 EUROPE: BONE MEAL GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 27 ASIA PACIFIC: BONE MEAL GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.4 OTHER GELATIN SOURCES
TABLE 28 OTHER GELATIN SOURCE CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 29 NORTH AMERICA: OTHER GELATIN SOURCE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 30 EUROPE: OTHER GELATIN SOURCE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 31 ASIA PACIFIC: OTHER GELATIN SOURCE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.3 NON-GELATIN CAPSULES
TABLE 32 NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 33 NON-GELATIN CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 34 NON-GELATIN CAPSULES MARKET, BY REGION, 2021–2028 (BILLION UNITS)
TABLE 35 NORTH AMERICA: NON-GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 36 EUROPE: NON-GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 37 ASIA PACIFIC: NON-GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.3.1 HYDROXYPROPYL METHYLCELLULOSE
6.3.1.1 HPMC dominates non-gelatin capsules market
TABLE 38 HYDROXYPROPYL METHYLCELLULOSE CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 39 NORTH AMERICA: HYDROXYPROPYL METHYLCELLULOSE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 40 EUROPE: HYDROXYPROPYL METHYLCELLULOSE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 41 ASIA PACIFIC: HYDROXYPROPYL METHYLCELLULOSE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.3.2 PULLULAN AND STARCH
6.3.2.1 High manufacturing costs offset advantageous aspects of pullulan and starch
TABLE 42 PULLULAN AND STARCH CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 43 NORTH AMERICA: PULLULAN AND STARCH CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 44 EUROPE: PULLULAN AND STARCH CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 45 ASIA PACIFIC: PULLULAN AND STARCH CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
7 EMPTY CAPSULES MARKET, BY FUNCTIONALITY
7.1 INTRODUCTION
TABLE 46 EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
7.2 IMMEDIATE-RELEASE CAPSULES
7.2.1 INCREASING APPLICATIONS OF IMMEDIATE-RELEASE CAPSULES TO PROPEL MARKET
TABLE 47 IMMEDIATE-RELEASE CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 48 NORTH AMERICA: IMMEDIATE-RELEASE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 49 EUROPE: IMMEDIATE-RELEASE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 50 ASIA PACIFIC: IMMEDIATE-RELEASE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
7.3 SUSTAINED-RELEASE CAPSULES
7.3.1 RISING USE OF SUSTAINED-RELEASE FORMULATIONS IN TREATING CHRONIC DISEASES TO DRIVE MARKET
TABLE 51 SUSTAINED-RELEASE CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 52 NORTH AMERICA: SUSTAINED-RELEASE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 53 EUROPE: SUSTAINED-RELEASE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 54 ASIA PACIFIC: SUSTAINED-RELEASE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
7.4 DELAYED-RELEASE CAPSULES
7.4.1 GROWING PREFERENCE FOR TARGETED DRUG DELIVERY TO FUEL MARKET GROWTH
TABLE 55 DELAYED-RELEASE CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 56 NORTH AMERICA: DELAYED-RELEASE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 57 EUROPE: DELAYED-RELEASE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 58 ASIA PACIFIC: DELAYED-RELEASE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
8 EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION
8.1 INTRODUCTION
TABLE 59 EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)
8.2 ANTIBIOTIC AND ANTIBACTERIAL DRUGS
8.2.1 EMERGENCE OF NOVEL ANTIBIOTICS IN CAPSULE FORM AND INCREASING INCIDENCE OF INFECTIOUS DISEASES TO DRIVE MARKET
TABLE 60 EMPTY CAPSULES MARKET FOR ANTIBIOTIC AND ANTIBACTERIAL DRUGS, BY REGION, 2021–2028 (USD MILLION)
TABLE 61 NORTH AMERICA: EMPTY CAPSULES MARKET FOR ANTIBIOTIC AND ANTIBACTERIAL DRUGS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 62 EUROPE: EMPTY CAPSULES MARKET FOR ANTIBIOTIC AND ANTIBACTERIAL DRUGS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 63 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR ANTIBIOTIC AND ANTIBACTERIAL DRUGS, BY COUNTRY, 2021–2028 (USD MILLION)
8.3 DIETARY SUPPLEMENTS
8.3.1 RISING DEMAND FOR DIETARY SUPPLEMENTS TO SUPPORT GROWTH
TABLE 64 EMPTY CAPSULES MARKET FOR DIETARY SUPPLEMENTS, BY REGION, 2021–2028 (USD MILLION)
TABLE 65 NORTH AMERICA: EMPTY CAPSULES MARKET FOR DIETARY SUPPLEMENTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 66 EUROPE: EMPTY CAPSULES MARKET FOR DIETARY SUPPLEMENTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 67 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR DIETARY SUPPLEMENTS, BY COUNTRY, 2021–2028 (USD MILLION)
8.4 ANTACID AND ANTIFLATULENT PREPARATIONS
8.4.1 INCREASING DEMAND FOR GASTROINTESTINAL FORMULATIONS TO DRIVE MARKET
TABLE 68 EMPTY CAPSULES MARKET FOR ANTACID AND ANTIFLATULENT PREPARATIONS, BY REGION, 2021–2028 (USD MILLION)
TABLE 69 NORTH AMERICA: EMPTY CAPSULES MARKET FOR ANTACID AND ANTIFLATULENT PREPARATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 70 EUROPE: EMPTY CAPSULES MARKET FOR ANTACID AND ANTIFLATULENT PREPARATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 71 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR ANTACID AND ANTIFLATULENT PREPARATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
8.5 ANTIANEMIC PREPARATIONS
8.5.1 RISING INCIDENCE OF ANEMIA WORLDWIDE TO DRIVE GROWTH
TABLE 72 EMPTY CAPSULES MARKET FOR ANTIANEMIC PREPARATIONS, BY REGION, 2021–2028 (USD MILLION)
TABLE 73 NORTH AMERICA: EMPTY CAPSULES MARKET FOR ANTIANEMIC PREPARATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 74 EUROPE: EMPTY CAPSULES MARKET FOR ANTIANEMIC PREPARATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 75 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR ANTIANEMIC PREPARATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
8.6 ANTI-INFLAMMATORY DRUGS
8.6.1 RISING EMPHASIS ON GENERICS TO FAVOR MARKET GROWTH
TABLE 76 EMPTY CAPSULES MARKET FOR ANTI-INFLAMMATORY DRUGS, BY REGION, 2021–2028 (USD MILLION)
TABLE 77 NORTH AMERICA: EMPTY CAPSULES MARKET FOR ANTI-INFLAMMATORY DRUGS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 78 EUROPE: EMPTY CAPSULES MARKET FOR ANTI-INFLAMMATORY DRUGS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 79 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR ANTI-INFLAMMATORY DRUGS, BY COUNTRY, 2021–2028 (USD MILLION)
8.7 CARDIOVASCULAR THERAPY DRUGS
8.7.1 RISING PREVALENCE OF CARDIOVASCULAR DISEASES TO CONTRIBUTE TO MARKET GROWTH
TABLE 80 EMPTY CAPSULES MARKET FOR CARDIOVASCULAR THERAPY DRUGS, BY REGION, 2021–2028 (USD MILLION)
TABLE 81 NORTH AMERICA: EMPTY CAPSULES MARKET FOR CARDIOVASCULAR THERAPY DRUGS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 82 EUROPE: EMPTY CAPSULES MARKET FOR CARDIOVASCULAR THERAPY DRUGS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 83 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR CARDIOVASCULAR THERAPY DRUGS, BY COUNTRY, 2021–2028 (USD MILLION)
8.8 COUGH AND COLD DRUGS
8.8.1 GROWING ADOPTION OF OTC FORMULATIONS AND SELF-MEDICATION PRACTICES TO DRIVE GROWTH
TABLE 84 EMPTY CAPSULES MARKET FOR COUGH AND COLD DRUGS, BY REGION, 2021–2028 (USD MILLION)
TABLE 85 NORTH AMERICA: EMPTY CAPSULES MARKET FOR COUGH AND COLD DRUGS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 86 EUROPE: EMPTY CAPSULES MARKET FOR COUGH AND COLD DRUGS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 87 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR COUGH AND COLD DRUGS, BY COUNTRY, 2021–2028 (USD MILLION)
8.9 OTHER THERAPEUTIC APPLICATIONS
TABLE 88 EMPTY CAPSULES MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
TABLE 89 NORTH AMERICA: EMPTY CAPSULES MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 90 EUROPE: EMPTY CAPSULES MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 91 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
9 EMPTY CAPSULES MARKET, BY END USER
9.1 INTRODUCTION
TABLE 92 EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION)
9.2 PHARMACEUTICAL INDUSTRY
9.2.1 INCREASING EMPHASIS ON DRUG DEVELOPMENT TO DRIVE GROWTH
TABLE 93 EMPTY CAPSULES MARKET FOR PHARMACEUTICAL INDUSTRY, BY REGION, 2021–2028 (USD MILLION)
TABLE 94 NORTH AMERICA: EMPTY CAPSULES MARKET FOR PHARMACEUTICAL INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 95 EUROPE: EMPTY CAPSULES MARKET FOR PHARMACEUTICAL INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 96 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR PHARMACEUTICAL INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION)
9.3 NUTRACEUTICAL INDUSTRY
9.3.1 INCREASING DEMAND FOR DIETARY SUPPLEMENTS IN DEVELOPED AND DEVELOPING COUNTRIES TO SUPPORT GROWTH
TABLE 97 EMPTY CAPSULES MARKET FOR NUTRACEUTICAL INDUSTRY, BY REGION, 2021–2028 (USD MILLION)
TABLE 98 NORTH AMERICA: EMPTY CAPSULES MARKET FOR NUTRACEUTICAL INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 99 EUROPE: EMPTY CAPSULES MARKET FOR NUTRACEUTICAL INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 100 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR NUTRACEUTICAL INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION)
9.4 COSMETICS INDUSTRY
9.4.1 GELATIN-BASED CAPSULES ARE IDEAL FOR DELIVERING COSMETIC PRODUCTS
TABLE 101 EMPTY CAPSULES MARKET FOR COSMETICS INDUSTRY, BY REGION, 2021–2028 (USD MILLION)
TABLE 102 NORTH AMERICA: EMPTY CAPSULES MARKET FOR COSMETICS INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 103 EUROPE: EMPTY CAPSULES MARKET FOR COSMETICS INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 104 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR COSMETICS INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION)
9.5 RESEARCH LABORATORIES
9.5.1 RISING CLINICAL TRIAL ACTIVITY TO DRIVE MARKET GROWTH
TABLE 105 EMPTY CAPSULES MARKET FOR RESEARCH LABORATORIES, BY REGION, 2021–2028 (USD MILLION)
TABLE 106 NORTH AMERICA: EMPTY CAPSULES MARKET FOR RESEARCH LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 107 EUROPE: EMPTY CAPSULES MARKET FOR RESEARCH LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 108 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR RESEARCH LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION)
10 EMPTY CAPSULES MARKET, BY REGION
10.1 INTRODUCTION
TABLE 109 EMPTY CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 110 EMPTY CAPSULES MARKET, BY REGION, 2021–2028 (BILLION UNITS)
10.2 NORTH AMERICA
FIGURE 26 NORTH AMERICA: EMPTY CAPSULES MARKET SNAPSHOT
TABLE 111 NORTH AMERICA: EMPTY CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 112 NORTH AMERICA: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 113 NORTH AMERICA: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 114 NORTH AMERICA: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 115 NORTH AMERICA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
TABLE 116 NORTH AMERICA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)
TABLE 117 NORTH AMERICA: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION)
10.2.1 US
10.2.1.1 US to dominate North American market during forecast period
TABLE 118 US: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 119 US: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 120 US: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 121 US: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
TABLE 122 US: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)
TABLE 123 US: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION)
10.2.2 CANADA
10.2.2.1 Rising government focus on utilization of generics as means for controlling healthcare expenditure to drive growth
TABLE 124 CANADA: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 125 CANADA: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 126 CANADA: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 127 CANADA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
TABLE 128 CANADA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)
TABLE 129 CANADA: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION)
10.2.3 NORTH AMERICA: RECESSION IMPACT
10.3 EUROPE
TABLE 130 EUROPE: EMPTY CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 131 EUROPE: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 132 EUROPE: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 133 EUROPE: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 134 EUROPE: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
TABLE 135 EUROPE: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)
TABLE 136 EUROPE: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.1 GERMANY
10.3.1.1 Presence of large number of pharmaceutical and nutraceutical manufacturers propelling demand for empty capsules
TABLE 137 GERMANY: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 138 GERMANY: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 139 GERMANY: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 140 GERMANY: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
TABLE 141 GERMANY: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)
TABLE 142 GERMANY: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.2 UK
10.3.2.1 Rising adoption of generics to drive market growth
TABLE 143 UK: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 144 UK: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 145 UK: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 146 UK: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
TABLE 147 UK: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)
TABLE 148 UK: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.3 FRANCE
10.3.3.1 High demand for pharmaceutical products to drive market growth
TABLE 149 FRANCE: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 150 FRANCE: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 151 FRANCE: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 152 FRANCE: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
TABLE 153 FRANCE: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)
TABLE 154 FRANCE: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.4 ITALY
10.3.4.1 Growing presence of small and medium-sized CMOs likely to drive market
TABLE 155 ITALY: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 156 ITALY: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 157 ITALY: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 158 ITALY: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
TABLE 159 ITALY: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)
TABLE 160 ITALY: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.5 SPAIN
10.3.5.1 Consolidation of biotechnology sector and availability of government support to drive growth
TABLE 161 SPAIN: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 162 SPAIN: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 163 SPAIN: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 164 SPAIN: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
TABLE 165 SPAIN: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)
TABLE 166 SPAIN: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.6 REST OF EUROPE
TABLE 167 REST OF EUROPE: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 168 REST OF EUROPE: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 169 REST OF EUROPE: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 170 REST OF EUROPE: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
TABLE 171 REST OF EUROPE: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)
TABLE 172 REST OF EUROPE: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.7 EUROPE: RECESSION IMPACT
10.4 ASIA PACIFIC
FIGURE 27 ASIA PACIFIC: EMPTY CAPSULES MARKET SNAPSHOT
TABLE 173 ASIA PACIFIC: EMPTY CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 174 ASIA PACIFIC: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 175 ASIA PACIFIC: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 176 ASIA PACIFIC: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 177 ASIA PACIFIC: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
TABLE 178 ASIA PACIFIC: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)
TABLE 179 ASIA PACIFIC: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION)
10.4.1 CHINA
10.4.1.1 Low manufacturing costs on account of availability of raw materials to accelerate growth
TABLE 180 CHINA: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 181 CHINA: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 182 CHINA: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 183 CHINA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
TABLE 184 CHINA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)
TABLE 185 CHINA: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION)
10.4.2 JAPAN
10.4.2.1 Japan to be largest market for empty capsules in Asia Pacific
TABLE 186 JAPAN: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 187 JAPAN: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 188 JAPAN: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 189 JAPAN: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
TABLE 190 JAPAN: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)
TABLE 191 JAPAN: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION)
10.4.3 INDIA
10.4.3.1 Increased exports of empty capsules to drive market growth
TABLE 192 INDIA: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 193 INDIA: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 194 INDIA: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 195 INDIA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
TABLE 196 INDIA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)
TABLE 197 INDIA: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION)
10.4.4 REST OF ASIA PACIFIC
TABLE 198 REST OF ASIA PACIFIC: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 199 REST OF ASIA PACIFIC: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 200 REST OF ASIA PACIFIC: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 201 REST OF ASIA PACIFIC: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
TABLE 202 REST OF ASIA PACIFIC: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)
TABLE 203 REST OF ASIA PACIFIC: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION)
10.4.5 ASIA PACIFIC: RECESSION IMPACT
10.5 LATIN AMERICA
10.5.1 STRATEGIC EXPANSIONS BY LEADING MARKET PLAYERS TO DRIVE GROWTH
TABLE 204 LATIN AMERICA: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 205 LATIN AMERICA: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 206 LATIN AMERICA: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 207 LATIN AMERICA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
TABLE 208 LATIN AMERICA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)
TABLE 209 LATIN AMERICA: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION)
10.5.2 LATIN AMERICA: RECESSION IMPACT
10.6 MIDDLE EAST & AFRICA
10.6.1 GROWING PHARMACEUTICAL INDUSTRY TO DRIVE MARKET
TABLE 210 MIDDLE EAST & AFRICA: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 211 MIDDLE EAST & AFRICA: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 212 MIDDLE EAST & AFRICA: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 213 MIDDLE EAST & AFRICA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
TABLE 214 MIDDLE EAST & AFRICA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)
TABLE 215 MIDDLE EAST & AFRICA: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION)
10.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT
11 COMPETITIVE LANDSCAPE
11.1 INTRODUCTION
11.2 RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS
FIGURE 28 EMPTY CAPSULES MARKET: STRATEGIES ADOPTED
11.3 MARKET SHARE ANALYSIS
FIGURE 29 EMPTY CAPSULES MARKET: MARKET SHARE ANALYSIS, BY KEY PLAYER (2022)
TABLE 216 EMPTY CAPSULES MARKET: DEGREE OF COMPETITION
11.4 REVENUE ANALYSIS
FIGURE 30 REVENUE ANALYSIS FOR KEY COMPANIES (2020–2022)
11.5 COMPANY EVALUATION MATRIX
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 PARTICIPANTS
FIGURE 31 EMPTY CAPSULES MARKET: COMPANY EVALUATION MATRIX, 2022
11.6 COMPANY EVALUATION MATRIX FOR START-UPS/SMES
11.6.1 PROGRESSIVE COMPANIES
11.6.2 STARTING BLOCKS
11.6.3 RESPONSIVE COMPANIES
11.6.4 DYNAMIC COMPANIES
FIGURE 32 EMPTY CAPSULES MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2022
11.7 COMPETITIVE BENCHMARKING OF TOP 25 PLAYERS
11.7.1 OVERALL COMPANY FOOTPRINT (25 COMPANIES)
TABLE 217 OVERALL FOOTPRINT ANALYSIS OF KEY PLAYERS
11.7.2 INDUSTRY FOOTPRINT OF COMPANIES (25 COMPANIES)
TABLE 218 INDUSTRY FOOTPRINT ANALYSIS OF KEY PLAYERS
11.7.3 REGIONAL FOOTPRINT OF COMPANIES (25 COMPANIES)
TABLE 219 REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS
11.7.4 OFFERING FOOTPRINT OF COMPANIES (25 COMPANIES)
TABLE 220 OFFERING FOOTPRINT ANALYSIS OF KEY PLAYERS
11.8 COMPETITIVE BENCHMARKING OF START-UPS/SMES
TABLE 221 EMPTY CAPSULES MARKET: DETAILED LIST OF KEY START-UPS/SMES
TABLE 222 EMPTY CAPSULES MARKET: COMPETITIVE BENCHMARKING OF START-UPS/SMES
11.9 COMPETITIVE SCENARIO AND TRENDS
11.9.1 PRODUCT LAUNCHES
TABLE 223 EMPTY CAPSULES MARKET: PRODUCT LAUNCHES, JANUARY 2020–MARCH 2023
11.9.2 DEALS
TABLE 224 EMPTY CAPSULES MARKET: DEALS, JANUARY 2020–MARCH 2023
11.9.3 OTHER DEVELOPMENTS
TABLE 225 EMPTY CAPSULES MARKET: OTHER DEVELOPMENTS, JANUARY 2020–MARCH 2023
12 COMPANY PROFILES
(Business Overview, Products Offered, Recent Developments, MnM View Right to win, Strategic choices made, Weaknesses and competitive threats) *
12.1 KEY PLAYERS
12.1.1 CAPSUGEL (LONZA GROUP LTD.)
TABLE 226 CAPSUGEL (LONZA GROUP): BUSINESS OVERVIEW
FIGURE 33 LONZA GROUP LTD.: COMPANY SNAPSHOT (2022)
12.1.2 ACG
TABLE 227 ACG: BUSINESS OVERVIEW
12.1.3 MITSUBISHI CHEMICAL HOLDINGS CORPORATION
TABLE 228 QUALICAPS (MITSUBISHI CHEMICAL HOLDINGS CORPORATION): BUSINESS OVERVIEW
FIGURE 34 QUALICAPS (MITSUBISHI CHEMICAL HOLDINGS CORPORATION): COMPANY SNAPSHOT (2021)
12.1.4 CAPSCANADA CORPORATION
TABLE 229 CAPSCANADA CORPORATION: BUSINESS OVERVIEW
12.1.5 NATURAL CAPSULES
TABLE 230 NATURAL CAPSULES: BUSINESS OVERVIEW
FIGURE 35 NATURAL CAPSULES: COMPANY SNAPSHOT (2021)
12.1.6 SUHEUNG
TABLE 231 SUHEUNG: BUSINESS OVERVIEW
12.1.7 NECTAR LIFESCIENCES LTD.
TABLE 232 NECTAR LIFESCIENCES LTD.: BUSINESS OVERVIEW
FIGURE 36 NECTAR LIFESCIENCES LTD.: COMPANY SNAPSHOT (2021)
12.1.8 QINGDAO YIQING MEDICINAL CAPSULE (BAOTOU DONGBAO BIOTECHNOLOGY CO., LTD.)
TABLE 233 QINGDAO YIQING MEDICINAL CAPSULE: BUSINESS OVERVIEW
12.1.9 SHANXI GUANGSHENG MEDICINAL CAPSULE
TABLE 234 SHANXI GUANGSHENG MEDICINAL CAPSULE: BUSINESS OVERVIEW
12.1.10 HEALTHCAPS INDIA
TABLE 235 HEALTHCAPS INDIA: BUSINESS OVERVIEW
12.1.11 MEDI-CAPS
TABLE 236 MEDI-CAPS: BUSINESS OVERVIEW
FIGURE 37 MEDI-CAPS: COMPANY SNAPSHOT (2021)
12.1.12 SNAIL PHARMA INDUSTRY
TABLE 237 SNAIL PHARMA INDUSTRY: BUSINESS OVERVIEW
12.1.13 ROXLOR
TABLE 238 ROXLOR: BUSINESS OVERVIEW
12.1.14 SUNIL HEALTHCARE
TABLE 239 SUNIL HEALTHCARE: BUSINESS OVERVIEW
FIGURE 38 SUNIL HEALTHCARE: COMPANY SNAPSHOT (2021)
12.1.15 BIOCAPS ENTERPRISE
TABLE 240 BIOCAPS ENTERPRISE: BUSINESS OVERVIEW
12.1.16 BRIGHT PHARMA CAPS
TABLE 241 BRIGHT PHARMA CAPS: BUSINESS OVERVIEW
12.2 OTHER COMPANIES
12.2.1 COMED CHEMICALS
TABLE 242 COMED CHEMICALS: BUSINESS OVERVIEW
12.2.2 SAVIOUR CAPS
TABLE 243 SAVIOUR CAPS: BUSINESS OVERVIEW
12.2.3 FORTCAPS HEALTHCARE
TABLE 244 FORTCAPS HEALTHCARE: BUSINESS OVERVIEW
12.2.4 SHAOXING ZHONGYA CAPSULE
TABLE 245 SHAOXING ZHONGYA CAPSULE: BUSINESS OVERVIEW
12.2.5 ERAWAT PHARMA LIMITED
TABLE 246 ERAWAT PHARMA LIMITED: BUSINESS OVERVIEW
12.2.6 FARMACAPSULAS
TABLE 247 FARMACAPSULAS: BUSINESS OVERVIEW
12.2.7 ZHEJIANG YUEXI CAPSULE
12.2.8 LFA MACHINES OXFORD
12.2.9 SHAOXING KANGKE CAPSULE
12.2.10 SHREE PHARMA CAPS
*Details on Business Overview, Products Offered, Recent Developments, MnM View, Right to win, Strategic choices made, Weaknesses and competitive threats might not be captured in case of unlisted companies.
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
This research study involved the usage of widespread secondary sources; directories; databases such as Hoovers, Bloomberg, Businessweek, Factiva, and OneSource; white papers; annual reports; company house documents; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the global empty capsules market. It was also used to obtain important information about the top players, market classification, and segmentation according to the industry trends to the bottom-most level, geographical markets, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.
In the primary research process, various sources from both supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology and innovation directors, and related key executives from various key companies and manufacturers operating in the empty capsules market. The primary sources from the demand side include industry experts from contract capsule manufacturing service providers, pharmaceutical and nutraceutical manufacturers, research laboratories, and contract pharmaceutical manufacturing organizations.
Primary research was conducted to identify the segmentation types; industry trends; porter’s analysis; key players; competitive landscape of capsule products supplied by different types of market players; and key market dynamics such as drivers, restraints, opportunities, burning issues, industry trends, and key player strategies.
